Brian Clarke

ORCID: 0000-0003-3772-2202
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Ischemic Stroke Management
  • Transplantation: Methods and Outcomes
  • Cardiac Structural Anomalies and Repair
  • Mechanical Circulatory Support Devices
  • Heart Failure Treatment and Management
  • Intracerebral and Subarachnoid Hemorrhage Research
  • Cardiac Imaging and Diagnostics
  • Muscle Physiology and Disorders
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Cardiac Arrest and Resuscitation
  • Renal Transplantation Outcomes and Treatments
  • Cardiovascular Function and Risk Factors
  • COVID-19 Clinical Research Studies
  • Atrial Fibrillation Management and Outcomes
  • Water Systems and Optimization
  • Cerebrovascular and Carotid Artery Diseases
  • Cardiac pacing and defibrillation studies
  • Stroke Rehabilitation and Recovery
  • Child Nutrition and Water Access
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Viral Infections and Immunology Research
  • Venous Thromboembolism Diagnosis and Management
  • Infrastructure Maintenance and Monitoring
  • Cardiac Health and Mental Health
  • Ubiquitin and proteasome pathways

University of British Columbia
2023-2024

St. Paul's Hospital
2023-2024

St George’s University Hospitals NHS Foundation Trust
2020-2024

University of Pavia
2023-2024

International Society for Heart and Lung Transplantation
2024

IFC Research (United Kingdom)
2024

Shore Memorial Hospital
2023

Libin Cardiovascular Institute of Alberta
2016-2022

University of Calgary
2016-2022

New York Proton Center
2022

Skeletal muscle adapts to decreases in activity and load by undergoing atrophy. To identify candidate molecular mediators of atrophy, we performed transcript profiling. Although many genes were up-regulated a single rat model only small subset was universal all atrophy models. Two these encode ubiquitin ligases: Muscle RING Finger 1 ( MuRF1 ), gene designate Atrophy F-box MAFbx the latter being member SCF family E3 ligases. Overexpression myotubes produced whereas mice deficient either or...

10.1126/science.1065874 article EN Science 2001-11-23

Extracellular signals often result in simultaneous activation of both the Raf-MEK-ERK and PI3K-Akt pathways (where ERK is extracellular-regulated kinase, MEK mitogen-activated protein kinase or PI3K phosphatidylinositol 3-kinase). However, these two signaling were shown to exert opposing effects on muscle cell hypertrophy. Furthermore, pathway was inhibit pathway; this cross-regulation depended differentiation state cell: Akt inhibited differentiated myotubes, but not their myoblast...

10.1126/science.286.5445.1738 article EN Science 1999-11-26

Molecular mechanisms underlying sarcopenia, the age-related loss of skeletal muscle mass and function, remain unclear. To identify molecular changes that correlated best with sarcopenia might contribute to its pathogenesis, we determined global gene expression profiles in muscles rats aged 6, 12, 18, 21, 24, 27 months. These exhibit beginning at 21 Correlation versus or age changes, functional annotation analysis identified signatures distinct from aging. Specifically, mitochondrial energy...

10.1128/mcb.01036-12 article EN Molecular and Cellular Biology 2012-10-30
Ratika Parkash George A. Wells Jean L. Rouleau Mario Talajic Vidal Essebag and 95 more Allan C. Skanes Stephen B. Wilton Atul Verma Jeff S. Healey Laurence D. Sterns Matthew T. Bennett Jean-François Roux Léna Rivard Peter Leong‐Sit Mats Jensen‐Urstad Umjeet Jolly François Philippon John L. Sapp Anthony Tang Paul C. MacDonald Matthew T. Bennett Santabhanu Chakrabarti John A. Yeung‐Lai‐Wah Andrew Ignaszewski Stanley Tung Shahnawaz Virani Marc W. Deyell Andrew Krahn Jason G. Andrade Lynn Straatman Mustafa Toma Graham C. Wong Matthew Wei Isabelle Greiss Jean‐Marc Raymond Benoit Coutu Paolo Costi Fadi Mansour Wouter Saint-Phard Isabelle Denis Julie Fleury Jean-François Roux F. Ayala‐Paredes Mariano Badra‐Verdu Charles Dussault Nadia Vachon Véronique Dagenais C. Lamoureux Jeff S. Healey Stuart J. Connolly CS Ribas Syamkumar Divakaramenon Jorge Wong Guy Amit Wendy L. Meyer Isabelle Nault Jean Champagne J. Sarrazin Gilles O’Hara François Philippon L. Blier Benoît Plourde Christian Steinburg Karine Roy Paule Banville Brigitte Ottinger Marie‐Eve Boucher Marina P. Sánchez Léna Rivard Marc Dubuc Peter G. Guerra Katia Dyrda Paul Khairy Laurent Macle Blandine Mondésert Denis Roy Mario Talajic Bernard Thibault Rafik Tadros Véronique Roy Damian Redfearn Hoshiar Abdollah Adrián Baranchuk Kevin Michael Christopher S. Simpson Sharlene Hammond Stephen B. Wilton Brian Clarke Carlos A. Morillo Vikas Kuriachan George D. Veenhuyzen Russell Quinn Derek V. Exner Jonathan G. Howlett Jennifer McKeage Peter Leong‐Sit Lorne J. Gula Allan C. Skanes Jaimie Manlucu Anthony Tang

Background: Atrial fibrillation (AF) and heart failure (HF) frequently coexist can be challenging to treat. Pharmacologically based rhythm control of AF has not proven superior rate control. Ablation-based was compared with evaluate if clinical outcomes in patients HF could improved. Methods: This a multicenter, open-label trial blinded outcome evaluation using central adjudication committee. Patients high-burden paroxysmal (>4 episodes 6 months) or persistent (duration <3 years) AF,...

10.1161/circulationaha.121.057095 article EN Circulation 2022-03-22
Shelagh B. Coutts Sandeep Ankolekar Ramana Appireddy Juan F. Arenillas Zarina Assis and 95 more Peter Bailey Philip A. Barber Rodrigo Bazán Brian Buck Kenneth Butcher Marie‐Christine Camden Bruce Campbell Leanne K. Casaubon Luciana Catanese Kausik Chatterjee Philip Choi Brian Clarke Dar Dowlatshahi Julia Ferrari Thalia S. Field Aravind Ganesh Darshan Ghia Mayank Goyal Stefan Greisenegger Omid Halse MacKenzie Horn Gary Hunter Oje Imoukhuede Peter J. Kelly James Kennedy Carol Kenney Timothy Kleinig Kailash Krishnan Fabrício Oliveira Lima Jennifer Mandzia Martha Marko Sheila Cristina Ouriques Martins George Medvedev Bijoy K. Menon Sachin Mishra Carlos A. Molina Aimen Moussaddy Keith W. Muir Mark Parsons Andrew M W Penn Arthur Pille Octávio Marques Pontes‐Neto Christine Roffe Joaquı́n Serena Robert Simister Nishita Singh Neil J. Spratt Daniel Strbian Carol Huilian Tham M Ivan Wiggam David Williams M Willmot Teddy Y. Wu Amy Yu George Zachariah Atif Zafar Charlotte Zerna Michael D. Hill Marina Salluzzi Nicole Blenkin Ashley Dueck Craig Doram Qiao Zhang Carol Kenney Karla J. Ryckborst Shelly Bohn Quentin Collier Frances Taylor Brendan Cord Lethebe Anitha Jambula Kayla Sage Lana Toussaint Supryia Save Jaclyn Lee Nihay Laham-Karam Asfia Sultan Deepak Agrawal A Sitaram Andrew M. Demchuk Andrew Lockey A. Micielli Ankur Wadhwa Babawale Arabambi B Graham Chrysi Bogiatzi Darshan Doshi Debabrata Chakraborty Diana Kim Denise Vasquez D Singh Dominic Tse Earl C. Harrison Eric E. Smith Erika Teleg Evgenia Klourfeld

10.1016/s0140-6736(24)00921-8 article EN The Lancet 2024-05-17

Abstract Background and aim Neutrophil-lymphocyte ratio (NLR) lymphocyte-monocyte (LMR) are associated with clinical outcomes in malignancy, cardiovascular disease stroke. Here we investigate their association outcome after acute ischaemic stroke treated by mechanical thrombectomy (MT). Methods Patients were selected using audit data for MT anterior circulation at a UK centre from May 2016–July 2017. Clinical laboratory including neutrophil, lymphocyte monocyte count tested before 24 h...

10.1186/s12974-020-01739-y article EN cc-by Journal of Neuroinflammation 2020-02-18

The mRNA vaccines against COVID-19 infection have been effective in reducing the number of symptomatic cases worldwide. With widespread uptake, case series vaccine-related myocarditis/pericarditis reported, particularly adolescents and young adults. Men tend to be affected with greater frequency, symptom onset is usually within 1 week after vaccination. Clinical course appears mild most cases. On basis available evidence, we highlight a clinical framework guide providers on how assess,...

10.1016/j.cjca.2021.08.001 article EN other-oa Canadian Journal of Cardiology 2021-08-08
Martina Goeldlin Arsany Hakim Mattia Branca Stefanie Abend Markus Kneihsl and 95 more Waldo Valenzuela Sabine Fenzl Beata Rezny‐Kasprzak Roman Rohner Daniel Strbian Maurizio Paciaroni Götz Thomalla Patrik Michel Krassen Nedeltchev Thomas Gattringer Else Charlotte Sandset Leo H. Bonati Diana Aguiar de Sousa PN Sylaja George Ntaios Masatoshi Koga Zuzana Gdovinová Robin Lemmens Natan M. Bornstein Peter J. Kelly Mira Katan Thomas Horvath Jesse Dawson Urs Fischer Adedolapo Kamaldee Adeyemi Vedamurthy Adhiyaman Adrian Scutelnic Hisanao Akiyama A. Wilson Alexander A. Tarnutzer Alexander Pichler Alexander Salerno Alexander Vanhoorne Alexandros A. Polymeris Ami Wilkinson Ana Paiva Nunes Anastasia Adamou André Peeters Andrea M. Humm Andrea Zini Aneesh Dhasan Angelika Alonso Anna Fischer Anna Maija Saukkonen Anna Maria Müller Anne Berberich Anne Falcou Annemie Devroye Arne Hostens Arthur Liesz Arunkumar Annamalai Arvind Vijaysharan Sharma Asterios Paliantonis Aumugam Nallasivan Azmil H. Abdul‐Rahim Ben Grimshaw Bernd Kallmünzer Biljana Rodic Brian Clarke Brian Menezes B. Weder Carla Ciobanu Carlo W. Cereda Caroline M.J. Loos Caterina Kulyk Catia Gonçalves Martins Cecilia Ferrari Christian Fung Christina M. Caporale Christine McAlpine Christoph Globas Christoph Gumbinger Christophe Bonvin Christos Krogias Clare Whyte Claudio L. Bassetti Dan Ryan Daniel Charissé Daniel Richter Daniel Schrammel Daria Giudici Darius G. Nabavi David Bradley David Orion David Seiffge David J. Werring Davide Strambo Derek Esson Dheeraj Khurana Diana Melância Dimitre Staykov Dimitri Hemelsoet Dominik Michalski Eckhard Schlemm Efstathia Karagkiozi

Whether infarct size modifies the treatment effect of early vs late direct oral anticoagulant (DOAC) initiation in people with ischemic stroke and atrial fibrillation is unknown.

10.1001/jamaneurol.2024.1450 article EN JAMA Neurology 2024-05-28

Abstract Introduction There are few randomized clinical trials in vascular cognitive impairment (VCI). This trial tested the hypothesis that PDE5 inhibitor tadalafil, a widely used vasodilator, increases cerebral blood flow (CBF) older people with symptomatic small vessel disease, main cause of VCI. Methods In double‐blind, placebo‐controlled, cross‐over trial, participants received tadalafil (20 mg) and placebo on two visits ≥7 days apart (randomized to order treatment). The primary...

10.1002/alz.12559 article EN cc-by-nc-nd Alzheimer s & Dementia 2022-02-08

Purpose: Recombinant human interleukin-1 receptor antagonist (anakinra) is an anti-inflammatory with efficacy in animal models of stroke. We tested the effect anakinra on perihaematomal oedema acute intracerebral haemorrhage (ICH) and explored effects inflammatory markers. Methods: conducted a multicentre, randomised, double-blind, placebo-controlled trial patients acute, spontaneous, supratentorial ICH between May 2019 February 2021. Patients were randomised to 100 mg subcutaneous within 8...

10.1177/23969873231185208 article EN cc-by-nc European Stroke Journal 2023-07-15

A differential scanning calorimetric study was done on raw and parboiled rice to determine the degree of gelatinization. Unparboiled absorbed highest amount endothermic heat, enthalpy change gradually decreasing with increasing hot soaking time. The gelatinization achieved when paddy soaked for 120 min at 80 °C. With gelatinization, yield point in a compression test also increased. During parboiling process internal fissures were healed, resulting higher head during milling.

10.1046/j.1365-2621.2002.00611.x article EN International Journal of Food Science & Technology 2002-06-01

In diabetes mellitus the morbidity and mortality of cardiovascular disease is increased represents an important independent mechanism by which heart exacerbated. The pathogenesis diabetic cardiomyopathy involves enhanced activation PPAR transcription factors, including PPARα, to a lesser degree PPARβ PPARγ1. How these factors are regulated in largely unknown. Recent studies have described post-translational ubiquitination PPARs as ways activity inhibited cancer. However, specific mechanisms...

10.1186/s12933-015-0252-x article EN cc-by Cardiovascular Diabetology 2015-08-04

Background The overlap between cancer and cardiovascular care continues to expand, with intersections emerging before, during, following therapies. To date, emphasis has been placed on how therapeutics influence downstream cardiac health. However, whether active malignancy itself influences chamber volumes, function, or overall myocardial tissue health remains uncertain. We sought perform a comprehensive magnetic resonance‐based evaluation of in patients chemotherapy‐naïve comparison healthy...

10.1161/jaha.120.019811 article EN cc-by-nc-nd Journal of the American Heart Association 2021-04-21
Alexandros A. Polymeris Mattia Branca P.N. Sylaja Else Charlotte Sandset Diana Aguiar de Sousa and 95 more Götz Thomalla Maurizio Paciaroni Thomas Gattringer Daniel Strbian Sven Trelle Patrik Michel Krassen Nedeltchev Leo H. Bonati George Ntaios Masatoshi Koga Zuzana Gdovinová Robin Lemmens Natan M. Bornstein John Ly Martina Goeldlin Stefanie Abend Magdy Selim Mira Katan Thomas Horvath Jesse Dawson Urs Fischer Adedolapo Kamaldee Adeyemi Vedamurthy Adhiyaman Adrian Scutelnic Hisanao Akiyama A. Wilson Alexander Pichler Alexander Salerno Alexander Vanhoorne Ami Wilkinson Ana Paiva Nunes Anastasia Adamou André Peeters Andrea M. Humm Andrea Zini Aneesh Dhasan Angelika Alonso Anna Fischer Anna Maija Saukkonen Anna Maria Müller Anne Berberich Anne Falcou Annemie Devroye Arne Hostens Arsany Hakim Arthur Liesz Arunkumar Annamalai Arvind Vijaysharan Sharma Asterios Paliantonis Aumugam Nallasivan Azmil H. Abdul‐Rahim Beata Rezny‐Kasprzak Ben Grimshaw Bernd Kallmünzer Biljana Rodic Brian Clarke Brian Menezes B. Weder Carla Ciobanu Carlo W. Cereda Caroline M.J. Loos Caterina Kulyk Catia Gonçalves Martins Cecilia Ferrari Christian Fung Christina M. Caporale Christine McAlpine Christoph Globas Christoph Gumbinger Christophe Bonvin Christos Krogias Clare Whyte Claudio L. Bassetti Dan Ryan Daniel Charissé Daniel Richter Daniel Schrammel Daria Giudici Darius G. Nabavi David Bradley David Orion David Seiffge David J. Werring Davide Strambo Derek Esson Dheeraj Khurana Diana Melância Dimitre Staykov Dimitri Hemelsoet Dominik Michalski Eckhard Schlemm Efstathia Karagkiozi Elisabeth Olbert Espen Saxhaug Kristoffersen Evelyn Marcelis

Importance The net clinical effect of early vs later direct oral anticoagulant (DOAC) initiation after atrial fibrillation–associated ischemic stroke is unclear. Objective To investigate whether DOAC treatment associated with a benefit (NCB). Design, Setting, and Participants This was post hoc analysis the Early Versus Late Initiation Direct Oral Anticoagulants in Post–Ischaemic Stroke Patients With Atrial Fibrillation (ELAN) open-label randomized trial conducted across 103 sites 15...

10.1001/jamanetworkopen.2024.56307 article EN cc-by-nc-nd JAMA Network Open 2025-01-28
Coming Soon ...